Aspect Biosystems Ltd.
Aspect Biosystems is a privately held biotechnology company operating at the leading edge of 3D bioprinting and tissue engineering. Our proprietary Lab-on-a-Printer™ platform technology is enabling advances in understanding fundamental biology, disease research, development of therapeutics, and regenerative medicine. We also focus on strategically partnering with pharmaceutical and biotechnology companies, as well as academic researchers, to create physiologically and commercially relevant tissues. These tissues are used to advance the discovery and development of new drugs and therapies.